307
Participants
Start Date
November 30, 2009
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
LCZ696
50 mg, 100 mg and 200 mg tablets
Valsartan
40 mg, 80 mg and 160 mg tablets
Placebo
matching placebo to LCZ696 and Valsartan
Novartis Investigative Site, Caracas
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, Maracaibo
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Sarzana
Novartis Investigative Site, Wyomissing
Novartis Investigative Site, Somma Lombardo
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Casorate Primo
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, San Daniele del Friuli
Novartis Investigative Site, Nashville
Novartis Investigative Site, Seville
Novartis Investigative Site, Detroit
Novartis Investigative Site, Pisa
Novartis Investigative Site, Chicago
Novartis Investigative Site, Lincoln
Novartis Investigative Site, Grand Island
Novartis Investigative Site, Little Rock
Novartis Investigative Site, Oklahoma City
Novartis Investigative Site, Tulsa
Novartis Investigative Site, Houston
Novartis Investigative Site, Cosenza
Novartis Investigative Site, Hillsboro
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Piteşti
Novartis Investigative Site, Moscow
Novartis Investigative Site, Singapore
Novartis Investigative Site, Moscow
Novartis Investigative Site, Singapore
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, S.-Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Craiova
Novartis Investigative Site, Craiova
Novartis Investigative Site, Jaipur
Novartis Investigative Site, Jaipur
Novartis Investigative Site, Baia Mare
Novartis Investigative Site, Nagpur
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Mangalore
Novartis Investigative Site, Manipal
Novartis Investigative Site, Nagpur
Novartis Investigative Site, Caba
Novartis Investigative Site, Ciudad Autonoma de Bs As
Novartis Investigative Site, Ramos Mejía
Novartis Investigative Site, San Martín
Novartis Investigative Site, Corrientes
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Rosario
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, Goiânia
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, São José do Rio Preto
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Brampton
Novartis Investigative Site, Montreal
Novartis Investigative Site, Montreal
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Mumbai
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Ede
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Delft
Novartis Investigative Site, Goes
Novartis Investigative Site, Groningen
Novartis Investigative Site, Heerenveen
Novartis Investigative Site, Heerlen
Novartis Investigative Site, Hengelo
Novartis Investigative Site, Warszawa/Anin
Novartis Investigative Site, Piotrkow Trybunalski
Novartis Investigative Site, Sieradz
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Alicante
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY